CAPLIPOINT.NS Profit & Loss
Caplin Point Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:40
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹14.67 Bn | ₹16.94 Bn | ₹19.37 Bn | ₹21.87 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | ₹20.34 Bn | ₹23.03 Bn | SegmentRevenueFromOperations |
| Other Income | ₹0.56 Bn | ₹0.67 Bn | ₹0.96 Bn | ₹1.16 Bn | OtherIncome |
| Total Income | ₹15.23 Bn | ₹17.61 Bn | ₹20.34 Bn | ₹23.03 Bn | Income |
| Cost of Materials Consumed | ₹2.23 Bn | ₹2.40 Bn | ₹2.48 Bn | ₹3.57 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹5.19 Bn | ₹5.59 Bn | ₹5.76 Bn | ₹5.72 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-0.79 Bn | ₹-0.75 Bn | ₹-0.53 Bn | ₹-0.64 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹1.37 Bn | ₹1.44 Bn | ₹1.78 Bn | ₹1.99 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.01 Bn | ₹0.01 Bn | ₹0.01 Bn | ₹0.01 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹0.45 Bn | ₹0.53 Bn | ₹0.66 Bn | ₹0.73 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹2.25 Bn | ₹2.75 Bn | ₹3.42 Bn | ₹3.62 Bn | OtherExpenses |
| Total Expenses | ₹10.71 Bn | ₹11.97 Bn | ₹13.57 Bn | ₹15.00 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹4.51 Bn | ₹5.64 Bn | ₹6.77 Bn | ₹8.03 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹4.51 Bn | ₹5.64 Bn | ₹6.77 Bn | ₹8.03 Bn | ProfitBeforeTax |
| Tax Expense | ₹0.74 Bn | ₹1.03 Bn | ₹1.36 Bn | ₹1.53 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹3.77 Bn | ₹4.61 Bn | ₹5.41 Bn | ₹6.50 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹3.76 Bn | ₹4.57 Bn | ₹5.63 Bn | ₹6.41 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹49.62 | ₹60.19 | ₹70.57 | ₹84.36 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹49.18 | ₹59.90 | ₹70.25 | ₹84.11 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from CAPLIPOINT.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).